title: Phase I study of intratumoral application of recombinant human tumor necrosis factor.
authors.affiliation: Medizinische Klinik I, University of Cologne, F.R.G.
authors.forename: M G
authors.initials: MG
authors.lastname: Pfreundschuh
authors.forename: H T
authors.initials: HT
authors.lastname: Steinmetz
authors.forename: R
authors.initials: R
authors.lastname: Tüschen
authors.forename: V
authors.initials: V
authors.lastname: Schenk
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.forename: M
authors.initials: M
authors.lastname: Schaadt
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use
chemical_list: D014409:Tumor Necrosis Factor-alpha